Ourania Tatsis, EVP, Chief Reg. & Quality Officer at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 8,832 shares at $420.79 ($3.7M) on 2024-02-20, disclosed to the SEC on 2024-02-21.
Scheduled sale ($3.7M) by EVP, Chief Reg. & Quality Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $424.01 | 4,499 | $1.9M | 51.1% |
| 2 | $420.58 | 3,373 | $1.4M | 38.0% |
| 3 | $420.79 | 480 | $202K | 5.4% |
| 4 | $420.79 | 480 | $202K | 5.4% |
| Total | $422.35 avg | 8,832 | $3.7M | 100% |
| Filing → |
| VRTX | SELL | 2026-02-19 | $472K | — | Filing → |
| VRTX | SELL | 2026-02-18 | $750K | — | Filing → |
| VRTX | SELL | 2026-02-12 | $215K | — | Filing → |